Ocular cancer, commonly referred to as eye cancer, represents a relatively uncommon yet formidable challenge in the realm of oncological research. Delving into the intricate mechanisms underlying its onset and progression, scientists probe the interplay between genetic predispositions, environmental triggers, and lifestyle influences. Cutting-edge imaging technologies facilitate early identification, enhancing prognosis and treatment outcomes. From targeted drug therapies to the promising frontier of immunomodulation, the therapeutic landscape is expanding, offering renewed hope for patients. Interdisciplinary collaboration among oncologists, ophthalmologists, and researchers remains pivotal in deciphering ocular cancer's complexities, driving forward strides in prevention, diagnosis, and tailored intervention strategies.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States